INGELHEIM, Germany & SINGAPORE--(BUSINESS WIRE)--Boehringer Ingelheim announced today that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a Phase 1 ...
Astro Announces Version 6 Beta with Redesigned Development Server and First-Class Cloudflare Workers
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. The panelists discuss the dramatic escalation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results